9. Daemen T, et, al. Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7. Gene Ther 2002;9(2):85-94 10. Natale C, Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences. Immunol cell biol 2000: 78: 580-5 ll. Villa ll, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol2000;8lPt12:2959-68 12. von Knebel Doeberitz M New molecular tools for efficient screening of cervical cancer. Dis Markers 2001: 17(3): 123-8 13. Boyle P, et al. Update on cancer control in women. Int J Gynaecol 0 bstet2000;70(2):263-303 14. Daemen T, et, al. Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7. Gene Ther 2002;9(2):85-9⎯ 3-4⎯ 9. Daemen T, et, al.Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7. Gene Ther 2002;9(2):85-94 10.Natale C, Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences. Immunol Cell Biol 2000;78:580-5 11.Villa LL,et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000;81 Pt 12:2959-68 12. von Knebel Doeberitz M.New molecular tools for efficient screening of cervical cancer. Dis Markers 2001;17(3):123-8 13. Boyle P,et al. Update on cancer control in women. Int J Gynaecol Obstet 2000;70(2):263-303 14. Daemen T, et, al.Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7. Gene Ther 2002;9(2):85-94